Biota Pharma to cut to two-thirds of workforce
June 2 (Reuters) - Biota Pharmaceuticals Inc said it plans to cut its workforce by about two-thirds and shut down its Melbourne, Australia, facility, following the loss of a key government contract.
The company's contract with the Department of Health and Human Services was supporting the development of its experimental influenza treatment.
Biota said it would incur related charges of about $5 million-$5.5 million. The company had 89 employees as of June 30, 2013. (Reporting by Natalie Grover in Bangalore)
- Alabama man gets $1,000 in police settlement, his lawyers get $459,000
- Two killed, four wounded in Washington state school shooting
- Two U.S. states to quarantine health workers returning from Ebola zones |
- NYC police say hatchet attack by Islam convert was terrorism |
- 'We won't pay,' furious Cameron tells EU over surprise bill |